FDA Approves Voluven to Treat Serious Blood Volume Loss following Surgery
The U.S. Food and Drug Administration today approved Voluven, an intravenous solution that prevents and treats a dangerous loss of blood volume, a condition that sometimes occurs during and after surgery.